Jared Holz, Mizuho Securities health care strategist, joins 'Fast Money' to discuss Eli Lilly's biggest day drop since 2008 ...

Wegovy and Zepbound are part of a wave of obesity medications known as GLP-1 receptor agonists that have soared in popularity ...

Pharmaceutical giant Eli Lilly alleges the companies are selling illegal off-brand versions of its best-selling diabetes and ...

Trump's Department of Commerce is looking into what it calls national security threats from overseas drug manufacturing, and Lilly CEO David Ricks has personally met with President Donald Trump in ...

A Tampa family celebrated their daughter's health milestone at the March of Dimes March for Babies walk. Lilly Lewellen spent ...

In its complaint against Fella Health, Lilly said the company made “sweeping corporate decisions that dictate patient care, such as when Fella changed patients en masse from one tirzepatide ...

Ricks said reshoring manufacturing capacity for older essential medicines is “a valid thing,” adding that Eli Lilly is “happy ...

Navigating ineffective weight management treatment is a sensitive process that requires acknowledgement of bias from both ...

Eli Lilly alleges Willow falsely claims its products are safe, effective and superior to its FDA-approved tirzepatide medicines, sold under Lilly's brand names: Mounjaro, which treats diabetes, and ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Option Care Health (OPCH – Research Report), Eli ...

NHS to trial prescribing the appetite-supressing drugs after a short consultation at a high street pharmacy as Government ...

In an internal memo, the World Health Organization signaled its support for anti-obesity drugs like Wegovy and Zepbound, ...